Regeneron Wins Higher Bar At Trial For FCA Kickback Theory

By Daniel Wilson · September 28, 2023, 7:30 PM EDT

A Massachusetts federal judge has ruled that the federal government must prove that alleged kickbacks by biotechnology company Regeneron related to its drug Eylea had a direct connection to false claims,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America v. Regeneron Pharmaceuticals, Inc.

Case Number

1:20-cv-11217

Court

Massachusetts

Nature of Suit

Other Statutes: False Claims Act

Date Filed

June 24, 2020